Related Experiment Video
Updated: Aug 18, 2026

The Unpredictable Chronic Mild Stress Protocol for Inducing Anhedonia in Mice
Published on: October 24, 2018
[N-acetylserotonin and hypotensive effect of MAO-A inhibitors]
1Department of Psychiatry, St. Elizabeth's Medical Center, Tufts University, Boston, Mass., USA.
Abstract:
Vladimir Zinovievich Gorkin's theory of the transformation of catalytic activity of amine oxidases and, therweby, selectivity of amine oxidases, carried over from my personal acquaintance with Vladimir Zinovievich, significantly influenced our studies into the mechanism of MAO-induced stimulation of pineal melatonin biosynthesis from serotonin. We found that this effect depended on the selective inhibition of MAO-A, but not MAO-B, which resulted in the increased formation of N-acetylserotonin (N-AS), the intermediate precursor of melatonin. The hypotensive effect of clorgyline was attenuated by pinealectomy, suggesting that increased N-AS and/or production might contribute to the hypotensive effect of selective MAO-A inhibition. Basal and isoproterenol-induced pineal levels of N-AS, but not melatonin, were lower in 12 week old (hypertensive) than in 4 week old (normotensive) spontaneously hypertensive (SHR) rats. N-AS decreased blood pressure in 12 week old SHR rats. The hypotensive effect of N-AS was augmented by pinealectome and by pretreatment with the S-adenosylhomocysteine, the inhibitor of N-AS conversion into melatonin. Our data demonstrate that hypotensive effect of N-AS is independent of its conversion to melatonin. We suggest that hypotensive effect of selective MAO-A inhibition might depend on the increased formation of N-AS, but not melatonin. The age-associated decrease in N-AS production may contribute to the developing of hypertension in SHR rats, and the age-associated increase of blood pressure in humans. Our data warrant the clinical trial of N-AS for the treatment of essential hypertension.
More Related Videos
07:56A Plate-Based Assay for the Measurement of Endogenous Monoamine Release in Acute Brain Slices
Published on: August 11, 2021
08:15Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
Related Concept Videos
Adrenergic Agonists: Indirect-Acting Agents
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
Drugs Affecting Neurotransmitter Release or Uptake
Drugs Affecting Neurotransmitter Synthesis
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Antidepressant Drugs: MAOIs and Other Agents
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists